Mechanism: Retatrutide is a triple agonist that targets GLP-1, GIP, and glucagon receptors
Key benefits include skin brightening, detoxification, immune support, and anti-aging effects
In a 48-week phase 2 study of retatrutide involving 338 overweight or obese non-diabetic participants, researchers observed dose-dependent decreases in weight and improvements in waist circumference, blood pressure, levels of glycated hemoglobin, fasting glucose and insulin, and most lipid metrics
GLP-1 receptor agonists solve that problem by mimicking the hormone's structure while resisting rapid degradation, allowing sustained activation of GLP-1 receptors across multiple tissues for hours or days, depending on the formulation [6]
We are preparing for everything we need to do so that everybody benefits from a lower price, both in diabetes and eventually in weight management, Mr